Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SYF2 encodes a nuclear protein that interacts with cyclin D-type binding-protein 1, which is thought to be a cell cycle regulator at the G1/S transition.
Showing 10 out of 35 products:
Human Polyclonal SYF2 Primary Antibody for IHC (p), ELISA - ABIN249706
Chang, Chang, Huang, Yang: p29, a novel GCIP-interacting protein, localizes in the nucleus. in Biochemical and biophysical research communications 2001
Disruption of mp29/Syf2/Ntc31 gene results in embryonic lethality with aberrant checkpoint response.
SYF2 might play a regulatory role in the proliferation of hepatocellular carcinoma cells.
we support that SYF2 might contribute to EOC progression via modulation of proliferation in EOC cells and would provide a novel therapeutic target of human epithelial ovarian cancer
p29 might contribute to the progression of non-small cell lung cancer by enhancing cell proliferation, implicating that targeting p29 might provide beneficial effects on the clinical therapy of non-small cell lung cancer
SYF2 in glioma is essential for cell proliferation.
Our findings for the first time supported that SYF2 might play an important role in the regulation of esophageal squamous cell carcinoma proliferation
novel function of p29 in the regulation of DNA replication checkpoint responses in Hela cells.
This gene encodes a nuclear protein that interacts with cyclin D-type binding-protein 1, which is thought to be a cell cycle regulator at the G1/S transition. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
, CCNDBP1 interactor
, GCIP-interacting protein p29
, SYF2 homolog, RNA splicing factor
, pre-mRNA-splicing factor syf2
, GCIP-interacting protein p29 (Gcipip)
, pre-mRNA-splicing factor SYF2
, functional spliceosome-associated protein 29